427 related articles for article (PubMed ID: 28137813)
1. Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
Baby N; Faust AC; Smith T; Sheperd LA; Knoll L; Goodman EL
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137813
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a pharmacy-driven methicillin-resistant Staphylococcus aureus surveillance protocol in pneumonia.
Dunaway S; Orwig KW; Arbogast ZQ; Myers ZL; Sizemore JA; Giancola SE
Int J Clin Pharm; 2018 Jun; 40(3):526-532. PubMed ID: 29721739
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist-Driven Methicillin-Resistant
Marinucci V; Louzon PR; Carr AL; Hayes J; Lopez-Ruiz A; Sniffen J
Ann Pharmacother; 2023 May; 57(5):560-569. PubMed ID: 36039495
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications.
Tong MC; Wisniewski CS; Wolf B; Bosso JA
Pharmacotherapy; 2016 Jul; 36(7):731-9. PubMed ID: 27208687
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic de-escalation in pneumonia with pharmacist education and ordering of methicillin-resistant
Doan K; Smoke S
Eur J Hosp Pharm; 2024 Jun; 31(4):327-331. PubMed ID: 36754620
[TBL] [Abstract][Full Text] [Related]
6. Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting.
Dadzie P; Dietrich T; Ashurst J
Cureus; 2019 Dec; 11(12):e6378. PubMed ID: 31938656
[TBL] [Abstract][Full Text] [Related]
7. Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration.
Renzoni AJ; Peksa GD; DeMott JM
Am J Emerg Med; 2021 Jun; 44():68-71. PubMed ID: 33581603
[TBL] [Abstract][Full Text] [Related]
8. Impact of a pharmacist-driven methicillin-resistant
Willis C; Allen B; Tucker C; Rottman K; Epps K
Am J Health Syst Pharm; 2017 Nov; 74(21):1765-1773. PubMed ID: 29070498
[TBL] [Abstract][Full Text] [Related]
9. Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.
Paonessa JR; Shah RD; Pickens CI; Lizza BD; Donnelly HK; Malczynski M; Qi C; Wunderink RG
Chest; 2019 May; 155(5):999-1007. PubMed ID: 30776365
[TBL] [Abstract][Full Text] [Related]
10. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
[TBL] [Abstract][Full Text] [Related]
11. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
[TBL] [Abstract][Full Text] [Related]
12. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
[TBL] [Abstract][Full Text] [Related]
13. The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin.
Equils O; da Costa C; Wible M; Lipsky BA
BMC Infect Dis; 2016 Sep; 16(1):476. PubMed ID: 27600290
[TBL] [Abstract][Full Text] [Related]
14. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Puzniak LA; Morrow LE; Huang DB; Barreto JN
Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Caffrey AR; Morrill HJ; Puzniak LA; Laplante KL
Pharmacotherapy; 2014 May; 34(5):473-80. PubMed ID: 24420846
[TBL] [Abstract][Full Text] [Related]
16. Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
Caffrey AR; Morrill HJ; Puzniak LA; LaPlante KL
Clin Ther; 2014 Apr; 36(4):552-9. PubMed ID: 24631473
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
Alaniz C; Pogue JM
Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction assay in critically ill patients with nosocomial pneumonia.
Smith MN; Erdman MJ; Ferreira JA; Aldridge P; Jankowski CA
J Crit Care; 2017 Apr; 38():168-171. PubMed ID: 27918901
[TBL] [Abstract][Full Text] [Related]
19. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
[TBL] [Abstract][Full Text] [Related]
20. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
